Trial Information

Summary: Extended Release Formula Double Blind/Placebo Study for Restless Legs Syndrome

Restless legs Treatment

The study will last approximately 4 months and will require you to have 10 office visits, 6 weekly and 4 bi-weekly. Labs, EKG's and neurological physical will be completed.

Patient Inclusion Criteria

• You must be 18 years of age
• Body mass index of less than 34
• Signed IRB approved Informed Consent
• Willing and able to follow study procedures
• Females of child bearing age MUST be on birth control

Patient Exclusion Criteria

• No other sleep disorders such as sleep apnea, insomnia, etc
• Uncontrolled Diabetes
• Neurological disease or movement disorder such as Multiple Sclerosis, Parkinson Disease
• History of alcohol or drug abuse in the past 12 months

This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.

Trial listings updated: June 1, 2008 at 5:46:14 AM